It seems Gilead is selling tons of Atripla these days:
Atripla is a 3-drug combo pill that includes Bristol-Myers Squibb's Sustiva, a potent non-nuke that often causes vivid dreams (and more rarely other central nervous system side effects) -- thus the headline of this post.
Gilead 4Q Profit Rises 43 Percent On Atripla SalesGilead Sciences said yesterday its profit climbed 43 percent in the fourth quarter due to rising sales of its three-in-one HIV drug Atripla. The company said sales of Atripla, which was approved in the U.S. in July 2006, jumped 50 percent compared to the fourth quarter of 2008. It said Atripla became its best-selling drug during the quarter, as revenue surpassed that of an older drug, Truvada. Gilead said its profit rose to $802.2 million, or 87 cents per share, from $560 million, or 59 cents per share.
Atripla is a 3-drug combo pill that includes Bristol-Myers Squibb's Sustiva, a potent non-nuke that often causes vivid dreams (and more rarely other central nervous system side effects) -- thus the headline of this post.Gilead is now the biggest seller of AIDS drugs in the world, selling a whopping $5.84 billion of antivirals last year.
I certainly hope they're giving back to affected communities -- generously and often. We all know Gilead has long-standing grants and charitable giving programs, but they should grow in proportion to their HIV sales. I've seen no evidence that they have.
Peter on:
Follow @PeterStaley
Comments on Peter Staley's blog entry "That's a Lot of Vivid Dreaming"
Thx Great Article!!!!
HI
Please tell me more about Atripla and more rarely other central nervous system side effects.
Thks
Gilead has had a lot of involment in the Philadelphia PA area from sponsoring Holiday events and cookouts to bringing info and meals into our drug and alcohol recovery houses. I see a lot of communinty help and I thank Roxanne Wolf for really doing a great job. Call Roxanne she'll help when she can
Hassan J Gibbs
PLWA since 1985
They'd better Goddamn well be giving back! Their profit climbed 43 percent in the fourth quarter due not only to rising sales, but because of price increases.
When I began taking Atripla back in March 2007, it cost roughly $900 a bottle (30 day supply). I watched as it rose, month after month to it's current price of over $1,800 and it sickens me (pardon the pun)!
I am grateful that this vital, virtually side-effect-free medication is available to me and am indebted to ADAP for paying for it, but seriously folks, I wish I had bought stock in big pharma.
Guess that means your stock portfolio has robustly improved, eh, Petey?
Do you have this information on the effect that SDC has on AIDS, MRSA, Virus & Bacteria?
http://www.microbecidegel.com/
Microbecide® Gel is a natural, water-based, non-staining, safe, smooth, lubricating gel that kills the Human Immunodeficiency Virus (HIV), the cause of Acquired Immunodeficiency Syndrome (AIDS) and Candida albicans, a fungus that causes "yeast" infection.
http://www.youtube.com/watch?v=BTzBmKD-jzU
The above link shows how SDC works
Avantages of SDC include:
Powerful broad spectrum protection as a disinfectant, fungicide and virucide
Kills germs in 30 seconds
Provides residual protection for 24 hours
Effective against resistant bacteria such as MRSA and VRE
Lowest toxicity rating available
Labeled for use in diverse environments including restaurants, homes, medical facilities, institutions, day care facilities and on children's toys and play areas
Unparalleled Efficacy
Category Axen-30® Leading Brands
Active Ingredient Silver dihydrogen citrate Ethanol/Ammonium Chloride
EPA Safety Category IV II
Standard Bacteria Kill Time 30 sec 10 min
Resistant Bacteria Kill Time 2 min None
Fungal/Virus Kill Time 10 min 10 min
Residual Protection 24 hour None
Rinse Required No Yes
Irritating Fumes No Yes
Skin Irritation No Yes
Flammable No Yes
Tulsa County Jail Eradicates Long-Standing Staph Problem: No New Cases in 16 Months with use of Staph Attack Disinfectant since introduction in August 2006. Product Now in Use in 14 Additional Correctional Facilities TULSA, OK, February 8, 2007-- Enviroguard Technologies LLC, distributors of Staph Attack, a new hard surface disinfectant containing PURE Bioscience(OTCBB: PURE) patented silver dihydrogen citrate, announced reports of outstanding success with the surface disinfectant that kills resistant forms of Staph. Tulsa County Jail reports that since the introduction of the product in August of last year, the jail has completely eliminated Staph infections, including MRSA, a resistant form of Staph.
The jail, with its 1700 cells and more than 1500 inmates, had historically faced challenges with a resistant form of Staph known as Methicillin Resistant Staphylococcus Aureus (MRSA). Prior to use of the new disinfectant, the facility experienced, on average, 12 cases of Staph infection every month.
According to Tulsa County Sheriff, Stanley Glanz, "We have been using Staph Attack for five months and have eliminated the reoccurrence of Staph infections in the facility. We are pleased to have created a healthier environment and at the same time save money."
As part of its regular cleaning and maintenance program, the jail now uses Staph Attack to disinfect booking areas, bathrooms, counter tops, cells and mattresses. Using Staph Attack has provided time and cost savings: The 24 hour residual protection offered by the product, combined with the lowest possible level of toxicity as defined by the EPA, means less frequent applications and no need for protective wear such as gloves and masks.
Staph Attack is presently being used in 15 different correctional facilities in 9 states, including Oklahoma, Kansas, Tennessee, Ohio, Minnesota, Louisiana, Pennsylvania, Florida and Texas.
Staph Attack is the silver-based hard surface disinfectant created by PURE Bioscience and distributed by Enviroguard Technologies specifically for closed populations where resistant bacteria are becoming increasingly problematic, such as hospitals, prisons and schools. Staph Attack carries EPA-registered claims against Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin resistant Enterococcus faecium (VRE), while maintaining the Category IV lowest-toxicity EPA rating. It kills the potentially deadly bacteria in just two minutes time and does not require rinsing.
How does it work?
Silver dihydrogen citrate (SDC), is an electrolytically generated source of stabilized ionic silver. In one of the mechanisms of action, the bacteria views the molecule as a food source, and once the organism consumes it, SDC destroys the bacteria by disabling proteins and halting its metabolic and reproductive functions. SDC is colorless, odorless, tasteless, non-caustic and formulates well with other compounds. As a platform technology, SDC is distinguished from competitors in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it.
www.purebio.com
Brand names:
http://www.sterifidelabs.com/
http://www.biosilver.net/
http://www.puregreen24.com/advantages.html
http://www.agion-tech.com/Technology.aspx?id=160
http://www.mrsanotes.com/staph-attack-for-infection-prevention/
http://www.odoban.com/
Pharmaceutical; synonymous with greed.